Advertisement

Topics

Fujirebio Diagnostics Inc. Company Profile

04:44 EDT 24th September 2017 | BioPortfolio


News Articles [1194 Associated News Articles listed on BioPortfolio]

Morphotek Announces An Agreement With Fujirebio Diagnostics, Inc. To Commercialize The CA125 II Assay As A Companion Diagnostic For Farletuzumab

  Life Sciences Jobs   ...

Morphotek®, Inc. Announces an Agreement with Fujirebio Diagnostics, Inc. to Commercialize the CA125 II Assay as a Companion Diagnostic for Farletuzumab®

EXTON, Pa., Sept. 5, 2017 /PRNewswire/ -- Morphotek®, Inc., a subsidiary of Eisai Inc., announced today that it entered into a collaboration and license agreement with Fujirebio Diagno...

Co-Diagnostics, Synbiotics launch joint venture CoSara Diagnostics in India

Co-Diagnostics, a molecular diagnostics company that has a unique, proprietary platform for the development of diagnostic tests, officially announced the recent incorporation of CoSara Diagnostics, a ...

IPO nets $6.4mm for Co-Diagnostics

Molecular diagnostics start-up Co-Diagnostics Inc. netted $6.4mm through its initial public offering of 1.18mm common shares at $6 each on the Nasdaq.

Japan HIV/AIDS Diagnostics Market: HIV 1/2, Combo, Ag, NAT, Western BlotSupplier Shares, Country Segment Volume and Sales Forecasts [Updated: 27062016] Prices from USD $1450

This DataPack presents Japanese test volume and sale forecasts for HIV1/2/Combo, HIV Ag, NAT, Western Blot and other confirmatory assays performed in the following market segments:nbsp;nbsp;nbsp; Hos...

20172021 Japan HIV/AIDS Diagnostics Market: HIV 1/2, Combo, Ag, NAT, Western BlotSupplier Shares, Country Segment Volume and Sales Forecasts [Updated: 30032017] Prices from USD $1450

This DataPack presents Japanese test volume and sale forecasts for HIV1/2/Combo, HIV Ag, NAT, Western Blot and other confirmatory assays performed in the following market segments:nbsp;nbsp;nbsp; Hos...

20172021 Japan HIV/AIDS Diagnostics Market: HIV 1/2, Combo, Ag, NAT, Western BlotSupplier Shares, Country Segment Volume and Sales Forecasts [Updated: 18012017] Prices from USD $1450

This DataPack presents Japanese test volume and sale forecasts for HIV1/2/Combo, HIV Ag, NAT, Western Blot and other confirmatory assays performed in the following market segments:nbsp;nbsp;nbsp; Hos...

Spain HIV/AIDS Diagnostics Market Segment Forecasts: HIV 1/2, Combo, Ag, NAT, Western Blot [Updated: 14072016] Prices from USD $900

This DataPack presents Spanish test volume and sale forecasts for HIV1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLVI/II and other confirmatory assays performed in the following market segments:nbsp;nbsp...

Drugs and Medications [20 Associated Drugs and Medications listed on BioPortfolio]

Oxygen [A.M. Home Diagnostics Inc. dba Healthline]

Oxygen

Cystografin dilute diatrizoate meglumine injection usp 18% [Bracco Diagnostics Inc.]

CYSTOGRAFIN DILUTE Diatrizoate Meglumine Injection USP 18%

Cystografin diatrizoate meglumine injection usp 30% [Bracco Diagnostics Inc.]

CYSTOGRAFIN Diatrizoate Meglumine Injection USP 30%

Multihance [Bracco Diagnostics Inc]

These highlights do not include all the information needed to use MultiHance safely and effectively. See full prescribing information for MultiHance. MultiHance (gadobenate dimeglumine) injection Init...

Reno-30 diatrizoate meglumine injection usp 30% [Bracco Diagnostics Inc.]

RENO-30 Diatrizoate Meglumine Injection USP 30%

PubMed Articles [266 Associated PubMed Articles listed on BioPortfolio]

Component resolved diagnostics for hymenoptera venom allergy.

Component-resolved diagnostics makes use of defined allergen molecules to analyse IgE-mediated sensitizations at a molecular level. Here, we review recent studies on the use of component-resolved diag...

Exploring the Case for a Global Alliance for Medical Diagnostics Initiative.

In recent years, the private and public sectors have increased investments in medical diagnostics for low- and middle-income countries (LMICs). Despite these investments, numerous barriers prevent the...

Comprehensive genetic study of cystic fibrosis in Slovak patients in 25 years of genetic diagnostics.

Cystic fibrosis (CF) has one of the longest histories in hereditary disease molecular diagnostics. However, identification of causative mutations in the CFTR gene is complicated by over two thousand c...

Advances in point-of-care technologies for molecular diagnostics.

Advances in miniaturization, nanotechnology, and microfluidics, along with developments in cloud-connected point-of-care (POC) diagnostics technologies are pushing the frontiers of POC devices toward ...

Local enamel demineralization diagnostics and treatment.

The article describes focal enamel demineralization - the most common disease of teeth hard tissues. Local and general factors of this pathological process advent and development were described. The m...

Clinical Trials [156 Associated Clinical Trials listed on BioPortfolio]

Differential Diagnostics of Etiology of Acute Infections

Method for diagnostics of the origin of infections (bacterial vs viral) based on the identification of activation markers of blood neutrophils and monocytes will be developed.

Bedside vs. Standard Microbiological Blood Culture Diagnostics - BEMIDIA Study

With a completely bedside blood culture diagnostics system (BACTEC blood culture system in combination with the Accelerate ID/AST System) it is possible to optimize the initial antimicrobi...

MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study

The purpose of this study is to assess the performance of the HTLV Blot 2.4 from patients with the following conditions: infected with HTLV and neurological conditions with symptoms simila...

HIV Point-of-Care Test Evaluation in Infants

HIV Point-of-Care tests in Babies Study (BABY) - Operational evaluation of HIV Point-of-Care tests for very early infant HIV diagnostics in infants born to HIV infected mothers in Mbeya, T...

Evaluation of the Performance of Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 Rapid Test

This study has been designed to evaluate the performance of the Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 rapid test. The device is intended to qualitatively detect the presence of ...

Companies [890 Associated Companies listed on BioPortfolio]

JFK Communications, Inc.

Fujirebio Diagnostics is the premier cancer diagnostics company and the industry leader in cancer biomarker assays. Fujirebio Diagnostics specializes in the clinical development, manufacturing and co...

Fujirebio Diagnostics,Inc

Formerly Certocor Diagnostics,Fujirebio Diagnostics,Inc.was acquired by ourparent company Fujirebio,Inc.of Tokyo,Japan in November 1998.

Gold Standard Diagnostics, Corp.

Fujirebio Diagnostics is the premier cancer diagnostics company and the industry leader in cancer biomarker assays. Fujirebio Diagnostics specializes in the clinical development, ...

Fujirebio Diagnostics Inc.

Sekisui Diagnostics

A Sekisui Chemical company since 2011, Sekisui Diagnostics is a leading supplier of high quality products to diagnostic manufacturers, clinical laboratories and physician offices ...

More Information about "Fujirebio Diagnostics Inc." on BioPortfolio

We have published hundreds of Fujirebio Diagnostics Inc. news stories on BioPortfolio along with dozens of Fujirebio Diagnostics Inc. Clinical Trials and PubMed Articles about Fujirebio Diagnostics Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Fujirebio Diagnostics Inc. Companies in our database. You can also find out about relevant Fujirebio Diagnostics Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record